研发-话题@MedSci

#研发#

826篇内容 | 7059人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1300493, encodeId=612a13004931f, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=强生HIV疫苗重大试验失败，HIV疫苗研发依然面临挑战, objectType=article, longId=217093, objectId=ab8f21e09342, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab8f21e09342, replyNumber=0, likeNumber=77, createdTime=2021-09-16, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab8f21e09342, moduleTitle=强生HIV疫苗重大试验失败，HIV疫苗研发依然面临挑战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab8f21e09342)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300492, encodeId=8f0713004928a, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=Medrxiv：抗体水平飙升78倍！陈薇院士团队研发新冠疫苗真有这么神奇?, objectType=article, longId=217009, objectId=9be721e009a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9be721e009a6, replyNumber=0, likeNumber=72, createdTime=2021-09-14, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9be721e009a6, moduleTitle=Medrxiv：抗体水平飙升78倍！陈薇院士团队研发新冠疫苗真有这么神奇?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9be721e009a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300491, encodeId=44ed1300491b4, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=2021年9月10日简报：中国完成德尔塔灭活疫苗临床前研究；莫德纳宣布研发新冠、流感二合一疫苗；美国75%成年人已至少接种一剂新冠疫苗, objectType=article, longId=216908, objectId=d9c22169080a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9c22169080a, replyNumber=0, likeNumber=55, createdTime=2021-09-11, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9c22169080a, moduleTitle=2021年9月10日简报：中国完成德尔塔灭活疫苗临床前研究；莫德纳宣布研发新冠、流感二合一疫苗；美国75%成年人已至少接种一剂新冠疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9c22169080a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300490, encodeId=b22a130049041, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=安帝康生物抗流感1类新药在中国获批临床，加速抗感染领域创新药研发, objectType=article, longId=216782, objectId=9260216e829f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9260216e829f, replyNumber=0, likeNumber=63, createdTime=2021-09-09, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9260216e829f, moduleTitle=安帝康生物抗流感1类新药在中国获批临床，加速抗感染领域创新药研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9260216e829f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300489, encodeId=0203130048971, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=天境生物半年报：将提交CD38抗体上市申请，启动“超级抗体”研发, objectType=article, longId=216610, objectId=18f6216610a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18f6216610a2, replyNumber=0, likeNumber=0, createdTime=2021-09-04, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18f6216610a2, moduleTitle=天境生物半年报：将提交CD38抗体上市申请，启动“超级抗体”研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18f6216610a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300487, encodeId=5344130048efe, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=辉诺医药宣布完成1亿元人民币A+轮融资，加速抗感染新药研发, objectType=article, longId=216512, objectId=c9ff21651289, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9ff21651289, replyNumber=0, likeNumber=68, createdTime=2021-09-02, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9ff21651289, moduleTitle=辉诺医药宣布完成1亿元人民币A+轮融资，加速抗感染新药研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c9ff21651289)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300486, encodeId=e67f1300486f4, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=新药研发利器PROTAC技术全面解析：原理，历史，优势，设计，挑战，机遇与下一代PROTAC技术, objectType=article, longId=216449, objectId=b3ec21644961, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3ec21644961, replyNumber=0, likeNumber=134, createdTime=2021-08-31, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3ec21644961, moduleTitle=新药研发利器PROTAC技术全面解析：原理，历史，优势，设计，挑战，机遇与下一代PROTAC技术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3ec21644961)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300484, encodeId=22671300484fc, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=善康医疗完成近2亿元B轮融资，加速精神药物研发 , objectType=article, longId=216390, objectId=c33321639014, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c33321639014, replyNumber=0, likeNumber=100, createdTime=2021-08-29, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c33321639014, moduleTitle=善康医疗完成近2亿元B轮融资，加速精神药物研发 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c33321639014)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300483, encodeId=98cf13004839b, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=科济药业发布2021年中期业绩自主研发 CAR-T候选品进入海外关键II期临床试验, objectType=article, longId=216260, objectId=c3532162608a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3532162608a, replyNumber=0, likeNumber=66, createdTime=2021-08-26, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3532162608a, moduleTitle=科济药业发布2021年中期业绩自主研发 CAR-T候选品进入海外关键II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3532162608a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300482, encodeId=4d631300482fe, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=艾博生物完成超7亿美元融资，国产mRNA新冠疫苗研发加速, objectType=article, longId=216034, objectId=ac3621603410, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac3621603410, replyNumber=0, likeNumber=69, createdTime=2021-08-21, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac3621603410, moduleTitle=艾博生物完成超7亿美元融资，国产mRNA新冠疫苗研发加速, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac3621603410)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300481, encodeId=2353130048160, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=2021年8月9日简报：全球多国停止新冠感染的检测与报告，实际病例应该远多于统计报告；口服新冠疫苗成为新的研发方向，EXO—CD24和非诺贝特有望用于新冠病毒的治疗, objectType=article, longId=215479, objectId=ffe52154e94c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ffe52154e94c, replyNumber=0, likeNumber=0, createdTime=2021-08-10, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ffe52154e94c, moduleTitle=2021年8月9日简报：全球多国停止新冠感染的检测与报告，实际病例应该远多于统计报告；口服新冠疫苗成为新的研发方向，EXO—CD24和非诺贝特有望用于新冠病毒的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ffe52154e94c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300480, encodeId=2c581300480ab, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=J Cosmet Dermatol：敏感肌，新研发的草药霜可有效减少红斑, objectType=article, longId=215427, objectId=9a5f21542e94, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a5f21542e94, replyNumber=0, likeNumber=70, createdTime=2021-08-09, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a5f21542e94, moduleTitle=J Cosmet Dermatol：敏感肌，新研发的草药霜可有效减少红斑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a5f21542e94)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300479, encodeId=8ca813004e980, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=PD-1/L1竞争再加剧，中国生物制药与康方生物研发的治疗鼻咽癌新药上市申请获国家药监局受理, objectType=article, longId=215388, objectId=bc0f21538845, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc0f21538845, replyNumber=0, likeNumber=76, createdTime=2021-08-08, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc0f21538845, moduleTitle=PD-1/L1竞争再加剧，中国生物制药与康方生物研发的治疗鼻咽癌新药上市申请获国家药监局受理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc0f21538845)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300478, encodeId=160e13004e80d, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=Lancet Infect Dis：陈薇团队研发的雾化吸入用新冠疫苗I期临床试验结果发布, objectType=article, longId=215013, objectId=499f215013f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=499f215013f2, replyNumber=0, likeNumber=80, createdTime=2021-07-30, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=499f215013f2, moduleTitle=Lancet Infect Dis：陈薇团队研发的雾化吸入用新冠疫苗I期临床试验结果发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=499f215013f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300488, encodeId=2f3913004880a, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=拜耳启动Elinzanetant III期临床研发项目OASIS，用于治疗更年期血管舒缩症状, objectType=article, longId=214643, objectId=e3b121464360, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3b121464360, replyNumber=0, likeNumber=74, createdTime=2021-07-24, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3b121464360, moduleTitle=拜耳启动Elinzanetant III期临床研发项目OASIS，用于治疗更年期血管舒缩症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3b121464360)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300477, encodeId=d5e413004e76e, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=首届AI药物研发创新研讨会在沪举行 , objectType=article, longId=214482, objectId=7fb1214482aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fb1214482aa, replyNumber=0, likeNumber=61, createdTime=2021-07-22, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fb1214482aa, moduleTitle=首届AI药物研发创新研讨会在沪举行 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fb1214482aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300476, encodeId=3d4913004e6af, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=复星医药与BioNTech研发的新冠疫苗通过中国专家组审核, objectType=article, longId=214285, objectId=9f1121428517, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f1121428517, replyNumber=0, likeNumber=57, createdTime=2021-07-17, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f1121428517, moduleTitle=复星医药与BioNTech研发的新冠疫苗通过中国专家组审核, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f1121428517)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300475, encodeId=4e5e13004e5da, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=Nat Commun：患者模型助力药物研发，体外再现小儿高级别胶质瘤的药物反应异质性 , objectType=article, longId=213780, objectId=edf2213e8023, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edf2213e8023, replyNumber=0, likeNumber=89, createdTime=2021-07-07, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edf2213e8023, moduleTitle=Nat Commun：患者模型助力药物研发，体外再现小儿高级别胶质瘤的药物反应异质性 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edf2213e8023)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300473, encodeId=709913004e33e, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=香港科大叶玉如团队研发简单血液测试可及早检测阿尔茨海默病, objectType=article, longId=213521, objectId=565021352151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=565021352151, replyNumber=0, likeNumber=67, createdTime=2021-07-01, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=565021352151, moduleTitle=香港科大叶玉如团队研发简单血液测试可及早检测阿尔茨海默病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=565021352151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300474, encodeId=12a313004e4ef, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=Claudin 18.2研发疾步向前多方大战一触即发, objectType=article, longId=213497, objectId=f59921349e47, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f59921349e47, replyNumber=0, likeNumber=82, createdTime=2021-07-01, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f59921349e47, moduleTitle=Claudin 18.2研发疾步向前多方大战一触即发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f59921349e47)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

研发

2020-05-29

lqvr (审核中...)

前往app查看评论内容

#研发#

强生HIV疫苗重大试验失败，HIV疫苗研发依然面临挑战

2021-09-16

lqvr (审核中...)

前往app查看评论内容

#研发#

Medrxiv：抗体水平飙升78倍！陈薇院士团队研发新冠疫苗真有这么神奇?

2021-09-14

lqvr (审核中...)

前往app查看评论内容

#研发#

2021年9月10日简报：中国完成德尔塔灭活疫苗临床前研究；莫德纳宣布研发新冠、流感二合一疫苗；美国75%成年人已至少接种一剂新冠疫苗

2021-09-11

lqvr (审核中...)

前往app查看评论内容

#研发#

安帝康生物抗流感1类新药在中国获批临床，加速抗感染领域创新药研发

2021-09-09

lqvr (审核中...)

前往app查看评论内容

#研发#

天境生物半年报：将提交CD38抗体上市申请，启动“超级抗体”研发

2021-09-04

lqvr (审核中...)

前往app查看评论内容

#研发#

辉诺医药宣布完成1亿元人民币A+轮融资，加速抗感染新药研发

2021-09-02

lqvr (审核中...)

前往app查看评论内容

#研发#

新药研发利器PROTAC技术全面解析：原理，历史，优势，设计，挑战，机遇与下一代PROTAC技术

2021-08-31

lqvr (审核中...)

前往app查看评论内容

#研发#

善康医疗完成近2亿元B轮融资，加速精神药物研发

2021-08-29

lqvr (审核中...)

前往app查看评论内容

#研发#

科济药业发布2021年中期业绩自主研发 CAR-T候选品进入海外关键II期临床试验

2021-08-26

lqvr (审核中...)

前往app查看评论内容

#研发#

艾博生物完成超7亿美元融资，国产mRNA新冠疫苗研发加速

2021-08-21

lqvr (审核中...)

前往app查看评论内容

#研发#

2021年8月9日简报：全球多国停止新冠感染的检测与报告，实际病例应该远多于统计报告；口服新冠疫苗成为新的研发方向，EXO—CD24和非诺贝特有望用于新冠病毒的治疗

2021-08-10

lqvr (审核中...)

前往app查看评论内容

#研发#

J Cosmet Dermatol：敏感肌，新研发的草药霜可有效减少红斑

2021-08-09

lqvr (审核中...)

前往app查看评论内容

#研发#

PD-1/L1竞争再加剧，中国生物制药与康方生物研发的治疗鼻咽癌新药上市申请获国家药监局受理

2021-08-08

lqvr (审核中...)

前往app查看评论内容

#研发#

Lancet Infect Dis：陈薇团队研发的雾化吸入用新冠疫苗I期临床试验结果发布

2021-07-30

lqvr (审核中...)

前往app查看评论内容

#研发#

拜耳启动Elinzanetant III期临床研发项目OASIS，用于治疗更年期血管舒缩症状

2021-07-24

lqvr (审核中...)

前往app查看评论内容

#研发#

首届AI药物研发创新研讨会在沪举行

2021-07-22

lqvr (审核中...)

前往app查看评论内容

#研发#

复星医药与BioNTech研发的新冠疫苗通过中国专家组审核

2021-07-17

lqvr (审核中...)

前往app查看评论内容

#研发#

Nat Commun：患者模型助力药物研发，体外再现小儿高级别胶质瘤的药物反应异质性

2021-07-07

lqvr (审核中...)

前往app查看评论内容

#研发#

香港科大叶玉如团队研发简单血液测试可及早检测阿尔茨海默病

2021-07-01

lqvr (审核中...)

前往app查看评论内容

#研发#

Claudin 18.2研发疾步向前多方大战一触即发

2021-07-01

科室
- - 订阅+
  - 更多科室
工具
服务